記事ID ： 36532

肥満や生活習慣病の研究にヒト皮下脂肪前駆細胞（Human Subcutaneous Preadipocytes）

カテゴリから探す > 細胞培養／細胞工学 > 初代培養細胞 > 肥満・糖尿病関連

メーカー名：Zen-Bio, Inc.

Zen-Bio社では、高品質のヒト脂肪前駆細胞を提供しております。
肥満度の異なる患者から採取されたこれらの細胞は、様々な分野の基礎研究、薬物スクリーニングに適しております。
また、すべての細胞は、脂質の蓄積、脂肪分解、およびアディポカインの分泌を含む、厳格な品質管理基準に合格しています。

HIV-1、HIV-2、HTLV-1、HTLV-2、B型肝炎、C型肝炎、およびマイコプラズマについて、陰性であることを確認しております。

*最新のドナー情報については、お問い合わせください。

【注意事項】
Zen-Bio社の細胞は、推奨の培地および、試薬を用いて、推奨プロトコルに従い培養された場合のみ品質を保証しております。

« Zen-Bio社ヒト初代培養細胞 TOPへ

ヒト皮下脂肪前駆細胞

品名	メーカー	品番	包装	希望販売価格
Cryopreserved, subcutaneous preadipocytes BMI<25.0	ZEN	SP-F-1	1 VIAL [2 x 10^6 cells/vial]	￥303,000
Cryopreserved, subcutaneous preadipocytes BMI 25.0-29.99	ZEN	SP-F-2	1 VIAL [2 x 10^6 cells/vial]	￥303,000
Cryopreserved, subcutaneous preadipocytes BMI >30.0	ZEN	SP-F-3	1 VIAL [2 x 10^6 cells/vial]	￥303,000
Cryopreserved, subcutaneous preadipocytes, (SUPERLOT-Pooled)	ZEN	SP-F-SL	1 VIAL [2 x 10^6 cells/vial]	￥303,000
Cryopreserved, subcutaneous from diabetic donor, LEAN DONOR, BMI<25.0	ZEN	SPD-F-1	1 VIAL [1 x 10^6 cells/vial]	お問い合わせ
Cryopreserved, subcutaneous from diabetic donorBMI 25-29.9	ZEN	SPD-F-2	1 VIAL [1 x 10^6 cells/vial]	お問い合わせ
Cryopreserved, subcutaneous from diabetic donorBMI >30.0	ZEN	SPD-F-3	1 VIAL [1 x 10^6 cells/vial]	お問い合わせ
Cryopreserved, subcutaneous breast	ZEN	BR-F	1 VIAL [1 x 10^6 cells/vial]	￥206,000
Cryopreserved, subcutaneous preadipocytes, FACE	ZEN	SQE-F	1 VIAL [1 x 10^6 cells/vial]	￥349,000
Cryopreserved, mesenteric preadipocytes from a diabetic donor	ZEN	MSND-F	1 VIAL [1 x 10^6 cells/vial]	販売終了

製品使用文献

Metabolic Benefits of MicroRNA-22 Inhibition. Thibonnier M, Esau C. Nucleic Acid Therapeutics. December 2019. doi:10.1089/nat.2019.0820
Identification and functional validation of genetic variants in potential miRNA target sites of established BMI genes. Kumar P, Traurig M, Baier LJ. Int J Obes (Lond). November 2019. doi:10.1038/s41366-019-0488-8
2-Aminoadipic acid (2-AAA) as a potential biomarker for insulin resistance in childhood obesity. Sci Rep. Lee HJ, Jang HB, Kim W-H, et al. 2019;9(1):13610. doi:10.1038/s41598-019-49578-z
Adipocytes Isolated from Visceral and Subcutaneous Depots of Donors Differing in BMI Crosstalk with Colon Cancer Cells and Modulate their Invasive Phenotype. Nimri L, Peri I, Yehuda-Shnaidman E, Schwartz B. Translational Oncology. 2019;12(11):1404-1415. doi:10.1016/j.tranon.2019.07.010
Cytoskeletal transgelin 2 contributes to gender-dependent adipose tissue expandability and immune function. Ortega FJ, Moreno-Navarrete JM, Mercader JM, et al. The FASEB Journal. 2019;33(8):9656-9671. doi:10.1096/fj.201900479R
Antiobesity effects of anthocyanins on mitochondrial biogenesis, inflammation, and oxidative stress: A systematic review. Gomes JVP, Rigolon TCB, Souza MS da S, et al. Nutrition. 2019;66:192-202. doi:10.1016/j.nut.2019.05.005
Phosphorylation status of fetuin-A is critical for inhibition of insulin action and is correlated with obesity and insulin resistance. Ren G, Kim T, Papizan JB, et al. American Journal of Physiology-Endocrinology and Metabolism. 2019;317(2):E250-E260. doi:10.1152/ajpendo.00089.2018
Comparative and functional analysis of plasma membrane-derived extracellular vesicles from obese vs. nonobese women. Santamaria-Martos F, Benitez ID, Latorre J, et al. Clinical Nutrition. 2019, doi:10.1016/j.clnu.2019.04.008
Modeling Tumor Phenotypes In Vitro with Three-Dimensional Bioprinting. Langer EM, Allen-Petersen BL, King SM, et al. Cell Reports. 2019;26(3):608-623.e6. doi:10.1016/j.celrep.2018.12.090
A Renewable Source of Human Beige Adipocytes for Development of Therapies to Treat Metabolic Syndrome. Su S, Guntur AR, Nguyen DC, et al. Cell Reports. 2018;25(11):3215-3228.e9. doi:10.1016/j.celrep.2018.11.037
Interleukin-1β and prostaglandin-synthesizing enzymes as modulators of human omental and subcutaneous adipose tissue function. Labrecque J, Michaud A, Gauthier M-F, et al. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2019;141:9-16. doi:10.1016/j.plefa.2018.11.015
Precocious subcutaneous abdominal stem cell development to adipocytes in normal-weight women with polycystic ovary syndrome. Fisch SC, Nikou AF, Wright EA, et al. Fertility and Sterility. 2018;110(7):1367-1376. doi:10.1016/j.fertnstert.2018.08.042
Adipose tissue TSH as a new modulator of human adipocyte mitochondrial function. Comas F, Lluch A, Sabater M, et al. Int J Obes. 2019;43(8):1611-1619. doi:10.1038/s41366-018-0203-1
Identification of protein kinase inhibitors to reprogram breast cancer cells. Yuan J, Zhang F, You M, Yang Q. Cell Death Dis. 2018;9(9):1-12. doi:10.1038/s41419-018-1002-2